• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison friction: experimental evidence from medicare drug plans.比较摩擦:来自医疗保险药品计划的实验证据。
Q J Econ. 2012;127(1):199-235. doi: 10.1093/qje/qjr055.
2
Medicare Part D: The First Fifteen Years.医疗保险 Part D:十五年历程。
Sr Care Pharm. 2021 Feb 1;36(2):124. doi: 10.4140/TCP.n.2021.124.
3
Medicare program; Medicare Advantage and prescription drug benefit programs. Final rule.医疗保险计划;医疗保险优势和处方药福利计划。最终规则。
Fed Regist. 2011 Sep 1;76(170):54600-35.
4
Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.医疗保险D部分:2008年面向计划主办方、药剂师及受益人的特定问题
J Manag Care Pharm. 2008 Jan-Feb;14(1):50-60. doi: 10.18553/jmcp.2008.14.1.50.
5
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划;医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
6
Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.最终短装规则对医疗保险D部分成本及长期护理药房配药的影响
Consult Pharm. 2012 Apr;27(4):269-73. doi: 10.4140/TCP.n.2012.269.
7
Medigap reform legislation of 1990: a 10-year review.1990年的医疗保险补充改革立法:十年回顾
Health Care Financ Rev. 2003 Spring;24(3):121-37.
8
Pharmaceuticals and Medical Devices: Medicare Part D.药品和医疗器械:医疗保险D部分
Issue Brief Health Policy Track Serv. 2016 Dec 27;2016:1-31.
9
PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.PDP 还是 MA-PD?CMS 第 25 区的医疗保险部分 D 注册决策。
Res Social Adm Pharm. 2010 Jun;6(2):130-42. doi: 10.1016/j.sapharm.2010.04.002.
10
A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.比较在零售和邮购药店配药的医疗保险处方药 D 部分的成本。
J Manag Care Spec Pharm. 2014 Sep;20(9):959-67. doi: 10.18553/jmcp.2014.20.9.959.

引用本文的文献

1
The Promotion of Preventive Behaviours in Healthcare Services: A Quantitative Study Among Older Adults in Spain.医疗保健服务中预防行为的促进:西班牙老年人的一项定量研究。
J Eval Clin Pract. 2025 Jun;31(4):e70108. doi: 10.1111/jep.70108.
2
Reading dies in complexity: Online news consumers prefer simple writing.阅读死于复杂:网络新闻消费者偏好简洁写作。
Sci Adv. 2024 Jun 7;10(23):eadn2555. doi: 10.1126/sciadv.adn2555. Epub 2024 Jun 5.
3
Risk communication clarity and insurance demand: The case of the COVID-19 pandemic.风险沟通的清晰度与保险需求:以新冠疫情为例
J Econ Dyn Control. 2023 Jan;146:104562. doi: 10.1016/j.jedc.2022.104562. Epub 2022 Nov 3.
4
Association of Medicare Advantage Premiums With Measures of Quality and Patient Experience.医疗保险优势保费与质量和患者体验衡量指标的关联。
JAMA Health Forum. 2022 Aug 5;3(8):e222826. doi: 10.1001/jamahealthforum.2022.2826.
5
Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018.2006-2018 年美国商业健康保险计划中退保和重新入保的趋势。
JAMA Netw Open. 2022 Feb 1;5(2):e220320. doi: 10.1001/jamanetworkopen.2022.0320.
6
"It's a mess sometimes": patient perspectives on provider responses to healthcare costs, and how informatics interventions can help support cost-sensitive care decisions.“有时一团糟”:患者对医疗服务提供者应对医疗费用的看法,以及信息学干预如何有助于支持对成本敏感的护理决策。
J Am Med Inform Assoc. 2022 May 11;29(6):1029-1039. doi: 10.1093/jamia/ocac010.
7
Clinic price reductions in a tiered total cost benefit design.按阶梯式总成本效益设计降低诊所价格。
Am J Manag Care. 2021 Sep 1;27(9):e316-e321. doi: 10.37765/ajmc.2021.88744.
8
The Modest Effects of Fact Boxes on Cancer Screening.信息框对癌症筛查的轻微影响。
J Risk Uncertain. 2021 Feb;62(1):29-54. doi: 10.1007/s11166-021-09344-x. Epub 2021 Feb 17.
9
How Financial Literacy and Impatience Shape Retirement Wealth and Investment Behaviors.金融知识与急躁如何塑造退休财富和投资行为。
J Pension Econ Financ. 2020 Jan;19(1):1-20. doi: 10.1017/s1474747218000227. Epub 2018 Sep 27.
10
Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D.私人提供的社会保险中的补贴设计:来自医疗保险D部分的经验教训。
J Polit Econ. 2020 May;128(5):1712-1752. doi: 10.1086/705550. Epub 2020 Mar 18.

本文引用的文献

1
The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.医疗保险处方药计划(Medicare Part D)对药品价格和使用的影响。
Am Econ Rev. 2010 Mar;100(1):590-607. doi: 10.1257/aer.100.1.590.
2
Part D Formulary and Benefit Design as a Risk-Steering Mechanism.D部分处方集与福利设计作为一种风险导向机制。
Am Econ Rev. 2011 May;101(3):382-386. doi: 10.1257/aer.101.3.382.
3
Choice Inconsistencies Among the Elderly: Evidence from Plan Choice in the Medicare Part D Program.老年人的选择不一致性:来自医疗保险处方药计划中计划选择的证据。
Am Econ Rev. 2011 Jun 1;101(4):1180-1210. doi: 10.1257/aer.101.4.1180.
4
Choice set size and decision making: the case of Medicare Part D prescription drug plans.选择集大小与决策:以医疗保险处方药计划为例。
Med Decis Making. 2010 Sep-Oct;30(5):582-93. doi: 10.1177/0272989X09357793. Epub 2010 Mar 12.
5
How much choice is too much? The case of the Medicare prescription drug benefit.多少选择才算过多?医疗保险处方药福利的案例。
Health Serv Res. 2009 Aug;44(4):1157-68. doi: 10.1111/j.1475-6773.2009.00981.x. Epub 2009 May 26.
6
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.医疗保险D部分处方药福利对药物使用和支出的影响。
Ann Intern Med. 2008 Feb 5;148(3):169-77. doi: 10.7326/0003-4819-148-3-200802050-00200. Epub 2008 Jan 7.
7
Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments.为何使用当前药物来选择医疗保险D部分计划可能会导致更高的自付费用。
Med Care Res Rev. 2008 Feb;65(1):114-26. doi: 10.1177/1077558707307577. Epub 2007 Oct 17.
8
Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.医疗保险处方药福利进展报告:2006年全国老年人调查结果
Health Aff (Millwood). 2007 Sep-Oct;26(5):w630-43. doi: 10.1377/hlthaff.26.5.w630. Epub 2007 Aug 21.
9
Who failed to enroll in Medicare Part D, and why? Early results.哪些人未能加入医疗保险D部分,原因是什么?初步结果。
Health Aff (Millwood). 2006 Sep-Oct;25(5):w344-54. doi: 10.1377/hlthaff.25.w344. Epub 2006 Aug 1.
10
Medicare prescription drug coverage: consumer information and preferences.医疗保险处方药覆盖范围:消费者信息与偏好
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7929-34. doi: 10.1073/pnas.0601837103. Epub 2006 May 8.

比较摩擦:来自医疗保险药品计划的实验证据。

Comparison friction: experimental evidence from medicare drug plans.

机构信息

Congressional Budget Office and National Bureau of Economic Research.

出版信息

Q J Econ. 2012;127(1):199-235. doi: 10.1093/qje/qjr055.

DOI:10.1093/qje/qjr055
PMID:22454838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3314343/
Abstract

Consumers need information to compare alternatives for markets to function efficiently. Recognizing this, public policies often pair competition with easy access to comparative information. The implicit assumption is that comparison friction—the wedge between the availability of comparative information and consumers' use of it—is inconsequential because when information is readily available, consumers will access this information and make effective choices. We examine the extent of comparison friction in the market for Medicare Part D prescription drug plans in the United States. In a randomized field experiment, an intervention group received a letter with personalized cost information. That information was readily available for free and widely advertised. However, this additional step—providing the information rather than having consumers actively access it—had an impact. Plan switching was 28% in the intervention group, versus 17% in the comparison group, and the intervention caused an average decline in predicted consumer cost of about $100 a year among letter recipients—roughly 5% of the cost in the comparison group. Our results suggest that comparison friction can be large even when the cost of acquiring information is small and may be relevant for a wide range of public policies that incorporate consumer choice.

摘要

消费者需要信息来比较不同的选择,以便市场有效运作。鉴于此,公共政策通常将竞争与易于获得比较信息相结合。隐含的假设是,比较摩擦——比较信息的可用性与消费者使用它之间的差距——是微不足道的,因为当信息易于获得时,消费者将访问这些信息并做出有效选择。我们考察了美国医疗保险处方药计划市场中比较摩擦的程度。在一项随机实地实验中,干预组收到了一封带有个性化成本信息的信。这些信息是免费的,并且广泛宣传。然而,提供信息而不是让消费者主动获取信息这一额外步骤产生了影响。干预组的计划转换率为 28%,而对照组为 17%,并且该干预措施导致收件人每年的预期消费者成本平均下降了约 100 美元,约为对照组成本的 5%。我们的结果表明,即使获取信息的成本很小,比较摩擦也可能很大,并且可能与许多纳入消费者选择的公共政策相关。